DNNGY vs. PFE
DNNGY (Orsted A/S ADR) and PFE (Pfizer Inc.) are both stocks. DNNGY operates in Utilities - Renewable (Utilities), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, DNNGY returned -29.45%/yr vs -3.66%/yr for PFE. At a 0.15 correlation, their price movements are largely independent.
Performance
DNNGY vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DNNGY achieves a 21.90% return, which is significantly higher than PFE's 4.10% return.
DNNGY
- 1D
- 3.92%
- 1M
- -14.19%
- YTD
- 21.90%
- 6M
- 24.68%
- 1Y
- -44.92%
- 3Y*
- -36.78%
- 5Y*
- -29.45%
- 10Y*
- —
PFE
- 1D
- -0.52%
- 1M
- -3.17%
- YTD
- 4.10%
- 6M
- 2.82%
- 1Y
- 11.94%
- 3Y*
- -7.59%
- 5Y*
- -3.66%
- 10Y*
- 1.96%
DNNGY vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DNNGY Orsted A/S ADR | 21.90% | -57.80% | -18.99% | -37.54% | -28.26% | -36.76% | 99.06% | 59.41% | 22.43% | -8.66% |
PFE Pfizer Inc. | 4.10% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 0.36% |
Correlation
The correlation between DNNGY and PFE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Oct 23, 2017 | 0.15 |
Fundamentals
DNNGY:
$30.44B
PFE:
$143.73B
DNNGY:
DKK 0.08
PFE:
$1.31
DNNGY:
612.69
PFE:
19.11
DNNGY:
51.32
PFE:
0.34
DNNGY:
1.93
PFE:
2.26
DNNGY:
1.63
PFE:
1.60
DNNGY:
DKK 67.84B
PFE:
$63.32B
DNNGY:
-DKK 7.31B
PFE:
$43.91B
DNNGY:
DKK 15.49B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DNNGY vs. PFE — Risk / Return Rank
DNNGY
PFE
DNNGY vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Orsted A/S ADR (DNNGY) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DNNGY | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.00 | ||
| Sortino ratioReturn per unit of downside risk | -1.11 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.11 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 1.05 | -1.63 |
| Martin ratioReturn relative to average drawdown | -0.77 | 2.06 | -2.83 |
Loading charts...
Drawdowns
DNNGY vs. PFE - Drawdown Comparison
The maximum DNNGY drawdown since its inception was -91.94%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for DNNGY and PFE.
Loading charts...
Drawdown Indicators
| DNNGY | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.94% | -69.24% | -22.70% |
Max Drawdown (1Y)Largest decline over 1 year | -76.54% | -11.47% | -65.07% |
Max Drawdown (3Y)Largest decline over 3 years | -81.92% | -37.69% | -44.23% |
Max Drawdown (5Y)Largest decline over 5 years | -89.18% | -58.96% | -30.22% |
Max Drawdown (10Y)Largest decline over 10 years | — | -58.96% | — |
Current DrawdownCurrent decline from peak | -89.25% | -48.02% | -41.23% |
Average DrawdownAverage peak-to-trough decline | -41.93% | -22.91% | -19.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.38% | 5.80% | +52.58% |
Volatility
DNNGY vs. PFE - Volatility Comparison
Orsted A/S ADR (DNNGY) has a higher volatility of 9.97% compared to Pfizer Inc. (PFE) at 5.40%. This indicates that DNNGY's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DNNGY | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.97% | 5.40% | +4.57% |
Volatility (6M)Calculated over the trailing 6-month period | 29.56% | 14.21% | +15.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 90.18% | 23.93% | +66.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.03% | 25.50% | +32.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.91% | 23.91% | +26.00% |
Dividends
DNNGY vs. PFE - Dividend Comparison
DNNGY has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.86%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNNGY Orsted A/S ADR | 0.00% | 0.00% | 0.00% | 3.56% | 2.09% | 1.46% | 0.48% | 0.89% | 1.43% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.86% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
DNNGY vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Orsted A/S ADR and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DNNGY vs. PFE - Profitability Comparison
DNNGY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Orsted A/S ADR reported a gross profit of 2.73B and revenue of 25.07B. Therefore, the gross margin over that period was 10.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
DNNGY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Orsted A/S ADR reported an operating income of 2.73B and revenue of 25.07B, resulting in an operating margin of 10.9%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
DNNGY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Orsted A/S ADR reported a net income of 2.36B and revenue of 25.07B, resulting in a net margin of 9.4%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
DNNGY and PFE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DNNGY has higher volatility (9.97%) compared to PFE (5.40%). In terms of maximum drawdown, DNNGY dropped -91.94% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.50 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DNNGY and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer